Press Release

Baylis Medical Expands Transseptal Portfolio with Launch of Steerable Guiding Sheath

September 10, 2018

TORONTO, SEPTEMBER 10, 2018 – Baylis Medical Company, a leader in the development, manufacturing and commercialization of cardiology devices, announced the official commercial launch of its SureFlex® Steerable Guiding Sheath.

The SureFlex sheath is part of Baylis’ rapidly growing portfolio of high-performance products for transseptal access. The sheath features an advanced sheath-to-dilator design for controlled crossing of the septum, intuitive and high-precision steering, and reliable performance through superior curve retention and consistent sheath tip contact force.

Steerable sheaths facilitate access in complex anatomies and hard-to-reach areas in the left side of the heart. Dr. Brian Powell, Medical Director of Electrophysiology practicing in Charlotte, North Carolina, finds them helpful with improving contact and subsequent outcomes in procedures such as atrial fibrillation and ventricular tachycardia ablations.

“When contact force sensing technology became available, it was an eye opener how much a steerable sheath improves contact,” said Dr. Powell. “The SureFlex sheath has good maneuverability and control. With the SureFlex sheath, I have not seen the flexion fatigue during long cases that I have experienced with similar sheaths. It maintains its ability to curl throughout the entire procedure.”

If a steerable sheath’s contact force and tip range of motion are not maintained during a procedure, it may result in clinical failure and necessitate additional revision procedures for the patient.

“Baylis is committed to continually developing sophisticated solutions that meet the needs of physicians, allowing them to deliver life-saving therapies to their patients,” said Neil Godara, Director of Research and Development at Baylis. “The launch of SureFlex further demonstrates our dedication to excellence in transseptal access following the global success of our NRG® Transseptal Needle.”

About Baylis Medical
Baylis Medical is a world leader in the development and commercialization of high-performance cardiology devices that help physicians deliver life-changing therapies to patients. Headquartered in Canada, and with offices world-wide, our clinical solutions have been Improving the Lives of People Around the World for over 30 years. For more information, visit and connect with us on Twitter, LinkedIn and Instagram.

PRM-00358 EN J-1,2,3 V-1 © Baylis Medical Company Inc., 2018. SureFlex, NRG and the Baylis Medical logo are trademarks and/or registered trademarks of Baylis Medical Company Inc. in the USA and/or other countries. Patents Pending and/or issued. CAUTION: Federal Law (USA) restricts the use of these devices to or by the order of a physician. Before use, consult product labels and Instructions for Use for Indications for Use, Contraindications, Warnings, Precautions, Adverse Events and Directions for Use.

Media Contact

Elissa Hanna
Corporate Communications Manager